Effect of Shiitake mushroom dose on colon tumorigenesis in azoxymethane-treated male Sprague-Dawley rats

Nutrition Research

Volumn 26, Issue 3, 2006, Pages 138-145

  Frank, Julie A ^a   Xiao, Rijin ^a,b   Yu, Shanggong ^a   Ferguson, Matthew ^a   Hennings, Leah J ^b   Simpson, Pippa M ^b   Ronis, Martin J J ^a,b   Fang, Nianbai ^a   Badger, Thomas M ^a,b   Simmen, Frank A ^a,b  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Aberrant crypt foci; Colon; Insulin; Mushroom; Rat; Shiitake; Tumor

Indexed keywords

CASEIN; SHIITAKE MUSHROOM EXTRACT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CANCER GROWTH; CARCINOGENESIS; COLON TUMOR; CONTROLLED STUDY; DRY POWDER; DUODENUM; ENERGY EXPENDITURE; INCIDENCE; INTESTINE TUMOR; LENTINUS EDODES; MALE; METABOLISM; NONHUMAN; OBESITY; PREVALENCE; PRIORITY JOURNAL; RAT; SMALL INTESTINE TUMOR;

ANIMALIA; BASIDIOMYCOTA; LENTINULA EDODES;

EID: 33646422788     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2006.03.001     Document Type: Article

References (46)

1. Chang R. Functional properties of edible mushrooms. Nutr Rev 54 11 Pt 2 (1996) S91-S93
2. Ribeiro L.R., and Salvadori D.M. Dietary components may prevent mutation-related diseases in humans. Mutat Res 544 (2003) 195-201
3. Borchers A.T., Keen C.L., and Gershwin M.E. Mushrooms, tumors, and immunity: an update. Exp Biol Med (Maywood) 229 (2004) 393-406
4. Ng M.L., and Yap A.T. Inhibition of human colon carcinoma development by lentinan from Shiitake mushrooms (Lentinus edodes). J Altern Complement Med 8 (2002) 581-589
5. Hara M., Hanaoka T., Kobayashi M., Otani T., Adachi H.Y., Montani A., et al. Cruciferous vegetables, mushrooms, and gastrointestinal cancer risks in a multicenter, hospital-based case-control study in Japan. Nutr Cancer 46 (2003) 138-147
6. Zaidman B.Z., Yassin M., Mahajna J., and Wasser S.P. Medicinal mushroom modulators of molecular targets as cancer therapeutics. Appl Microbiol Biotechnol 67 (2005) 453-468
7. Ikekawa T., Uehara N., Maeda Y., Nakanishi M., and Fukuoka F. Antitumor activity of aqueous extracts of edible mushrooms. Cancer Res 29 (1969) 734-735
8. Nanba H., and Kuroda H. Antitumor mechanisms of orally administered Shiitake fruit bodies. Chem Pharm Bull (Tokyo) 35 (1987) 2459-2464
9. Shamtsyan M., Konusova V., Maksimova Y., Goloshchev A., Panchenko A., Simbirtsev A., et al. Immunomodulating and anti-tumor action of extracts of several mushrooms. J Biotechnol 113 (2004) 77-83
10. Takimoto H., Wakita D., Kawaguchi K., and Kumazawa Y. Potentiation of cytotoxic activity in naive and tumor-bearing mice by oral administration of hot-water extracts from Agaricus brazei fruiting bodies. Biol Pharm Bull 27 (2004) 404-406
11. Bae J.S., Jang K.H., Yim H., Park S.C., and Jin H.K. Inhibitory effects of polysaccharides isolated from Phellinus gilvus on benzo(a)pyrene-induced forestomach carcinogenesis in mice. World J Gastroenterol 11 (2005) 577-579
12. Yu L., Fernig D.G., Smith J.A., Milton J.D., and Rhodes J.M. Reversible inhibition of proliferation of epithelial cell lines by Agaricus bisporus (edible mushroom) lectin. Cancer Res 53 (1993) 4627-4632
13. Bae J.S., Jang K.H., and Jin H.K. Effects of natural polysaccharides on the growth and peritoneal carcinomatosis of human gastric adenocarcinoma in a nude mouse model. Cancer Lett 235 (2006) 60-68
14. Fang N., Li Q., Yu S., Zhang J., He L., Ronis M.J.J., et al. Inhibition of growth and induction of apoptosis in human cancer cell lines by an ethyl acetate fraction from Shiitake mushrooms. J Altern Complement Med 12 (2006) 125-132
15. Toth B., Patil K., Pyysalo H., Stessman C., and Gannett P. Cancer induction in mice by feeding the raw false morel mushroom Gyromitra esculenta. Cancer Res 52 (1992) 2279-2284
16. Nanba H., Mori K., Toyomasu T., and Kuroda H. Antitumor action of Shiitake (Lentinus edodes) fruit bodies orally administered to mice. Chem Pharm Bull (Tokyo) 35 (1987) 2453-2458
17. Taguchi T. Effects of lentinan in advanced or recurrent cases of gastric, colorectal, and breast cancer. Gan To Kagaku Ryoho 10 2 Pt 2 (1983) 387-393
18. Chihara G. Experimental studies on growth inhibition and regression of cancer metastases. Gan To Kagaku Ryoho 12 (1985) 1196-1209
19. Okamoto T., Kodoi R., Nonaka Y., Fukuda I., Hashimoto T., Kanazawa K., et al. Lentinan from Shiitake mushroom (Lentinus edodes) suppresses expression of cytochrome P450 1A subfamily in the mouse liver. Biofactors 21 (2004) 407-409
20. Suga T., Shiio T., Maeda Y.Y., and Chihara G. Antitumor activity of lentinan in murine syngeneic and autochthonous hosts and its suppressive effect on 3-methylcholanthrene-induced carcinogenesis. Cancer Res 44 (1984) 5132-5137
21. Kurashige S., Akuzawa Y., and Endo F. Effects of Lentinus edodes, Grifola frondosa and Pleurotus ostreatus administration on cancer outbreak, and activities of macrophages and lymphocytes in mice treated with a carcinogen, N-butyl-N-butanolnitrosoamine. Immunopharmacol Immunotoxicol 19 (1997) 175-183
22. de Lima P.L., Delmanto R.D., Sugui M.M., da Eira A.F., Salvadori D.M., Speit G., et al. Letinula edodes (Berk.) Pegler (Shiitake) modulates genotoxic and mutagenic effects induced by alkylating agents in vivo. Mutat Res 496 (2001) 23-32
23. Sugui M.M., Alves de Lima P.L., Delmanto R.D., da Eira A.F., Salvadori D.M., and Ribeiro L.R. Antimutagenic effect of Lentinula edodes (Berk.) Pegler mushroom and possible variation among lineages. Food Chem Toxicol 41 (2003) 555-560
24. Bobek P., Galbavy S., and Ozdin L. Effect of oyster mushroom (Pleurotus ostreatus) on pathological changes in dimethylhydrazine-induced rat colon cancer. Oncol Rep 5 (1998) 727-730
25. Bobek P., and Galbavy S. Effect of pleuran (beta-glucan from Pleurotus ostreatus) on the antioxidant status of the organism and on dimethylhydrazine-induced precancerous lesions in rat colon. Br J Biomed Sci 58 (2001) 164-168
26. Jeannin J.F., Lagadec P., Pelletier H., Reisser D., Olsson N.O., Chihara G., et al. Regression induced by lentinan, of peritoneal carcinomatoses in a model of colon cancer in rat. Int J Immunopharmacol 10 (1988) 855-861
27. Mitamura T., Sakamoto S., Suzuki S., Yoshimura S., Maemura M., and Kudo H. Effects of lentinan on colorectal carcinogenesis in mice with ulcerative colitis. Oncol Rep 7 (2000) 599-601
28. Tran T.T., Medline A., and Bruce W.R. Insulin promotion of colon tumors in rats. Cancer Epidemiol Biomarkers Prev 5 (1996) 1013-1015
29. Kaaks R., Toniolo P., Akhmedkhanov A., Lukanova A., Biessy C., Dechaud H., et al. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women. J Natl Cancer Inst 92 (2000) 1592-1600
30. Ma J., Giovannucci E., Pollak M., Leavitt A., Tao Y., Gaziano J.M., et al. A prospective study of plasma C-peptide and colorectal cancer risk in men. J Natl Cancer Inst 96 (2004) 546-553
31. Qi H.L., Zhang Y., Ma J., Guo P., Zhang X.Y., and Chen H.L. Insulin/protein kinase B signalling pathway upregulates metastasis-related phenotypes and molecules in H7721 human hepatocarcinoma cell line. Eur J Biochem 270 (2003) 3795-3805
32. Kubo K., Aoki H., and Nanba H. Anti-diabetic activity present in the fruit body of Grifola frondosa (Maitake). Biol Pharm Bull 17 (1994) 1106-1110
33. Manohar V., Talpur N.A., Echard B.W., Lieberman S., and Preuss H.G. Effects of a water-soluble extract of maitake mushroom on circulating glucose/insulin concentrations in KK mice. Diabetes Obes Metab 4 (2002) 43-48
34. Talpur N.A., Echard B.W., Fan A.Y., Jaffari O., Bagchi D., and Preuss H.G. Antihypertensive and metabolic effects of whole Maitake mushroom powder and its fractions in two rat strains. Mol Cell Biochem 237 (2002) 129-136
35. Yang B.K., Kim D.H., Jeong S.C., Das S., Choi Y.S., Shin J.S., et al. Hypoglycemic effect of a Lentinus edodes exo-polymer produced from a submerged mycelial culture. Biosci Biotechnol Biochem 66 (2002) 937-942
36. Linz A.L., Xiao R., Parker J.G., Simpson P.M., Badger T.M., and Simmen F.A. Feeding of soy protein isolate to rats during pregnancy and lactation suppresses formation of aberrant crypt foci in their progeny's colons: interaction of diet with fetal alcohol exposure. J Carcinog 3 (2004) 14
37. Hakkak R., Korourian S., Ronis M.J., Johnston J.M., and Badger T.M. Soy protein isolate consumption protects against azoxymethane-induced colon tumors in male rats. Cancer Lett 166 (2001) 27-32
38. Xiao R., Carter J.A., Linz A.L., Ferguson M., Badger T.M., and Simmen F.A. Dietary whey protein lowers serum C-peptide concentration and duodenal SREBP-1c mRNA abundance, and reduces occurrence of duodenal tumors and colon aberrant crypt foci in azoxymethane-treated male rats. J Nutr Biochem (2006) [in press]
39. Coleman L.J., Landstrom E.K., Royle P.J., Bird A.R., and McIntosh G.H. A diet containing α-cellulose and fish oil reduces aberrant crypt foci formation and modulates other possible markers for colon cancer risk in azoxymethane-treated rats. J Nutr 132 (2002) 2312-2318
40. Nakaji S., Ishiguro S., Iwane S., Ohta M., Sugawara K., Sakamoto J., et al. The prevention of colon carcinogenesis in rats by dietary cellulose is greater than the promotive effect of dietary lard as assessed by repeated endoscopic observation. J Nutr 134 (2004) 935-939
41. Fukushima M., Ohashi T., Fujiwara Y., Sonoyama K., and Nakano M. Cholesterol-lowering effects of Maitake (Grifola frondosa) fiber, Shiitake (Lentinus edodes) fiber, and Enokitake (Flammulina velutipes) fiber in rats. Exp Biol Med (Maywood) 226 (2001) 758-765
42. Yan J., Zong H., Shen A., Chen S., Yin X., Shen X., et al. The beta-(1→6)-branched beta-(1→3) glucohexaose and its analogues containing an alpha-(1→3)-linked bond have similar stimulatory effects on the mouse spleen as lentinan. Int Immunopharmacol 3 (2003) 1861-1871
43. Holt P.R., Mokuolu A.O., Distler P., Liu T., and Reddy B.S. Regional distribution of carcinogen-induced colonic neoplasia in the rat. Nutr Cancer 25 (1996) 129-135
44. Shpitz B., Bomstein Y., Kariv N., Shalev M., Buklan G., and Bernheim J. Chemopreventive effect of aspirin on growth of aberrant crypt foci in rats. Int J Colorectal Dis 13 (1998) 169-172
45. Ghirardi M., Nascimbeni R., Villanacci V., Fontana M.G., Di Betta E., and Salerni B. Azoxymethane-induced aberrant crypt foci and colorectal tumors in F344 rats: sequential analysis of growth. Eur Surg Res 31 (1999) 272-280
46. Park H.S., Goodlad R.A., and Wright N.A. The incidence of aberrant crypt foci and colonic carcinoma in dimethylhydrazine-treated rats varies in a site-specific manner and depends on tumor histology. Cancer Res 57 (1997) 4507-4510